These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 5786360)

  • 21. Antagonism by tomoxetine of the depletion of norepinephrine and epinephrine in rat brain by alpha-methyl-m-tyrosine.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):169-72. PubMed ID: 6604933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders.
    Lambert G; Johansson M; Agren H; Friberg P
    Arch Gen Psychiatry; 2000 Aug; 57(8):787-93. PubMed ID: 10920468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between desipramine, tyramine, and amphetamine at adrenergic neurones.
    Brodie BB; Costa E; Groppetti A; Matsumoto C
    Br J Pharmacol; 1968 Nov; 34(3):648-58. PubMed ID: 5726793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin, cocaine and desipramine: comparison of effects on blood pressure responses to norepinephrine, tyramine and phenylephrine in the pithed rat.
    Pals DT; Fulton RW; Masucci FD
    J Pharmacol Exp Ther; 1968 Jul; 162(1):85-91. PubMed ID: 4297803
    [No Abstract]   [Full Text] [Related]  

  • 25. Action of the antidepressant pridefine (AHR-1118) on biogenic amines in the rat brain.
    Vosmer G; DeMet EM; Halaris AE
    Biochem Pharmacol; 1980 Oct; 29(19):2557-62. PubMed ID: 7426062
    [No Abstract]   [Full Text] [Related]  

  • 26. Biochemical basis of heart function. 3. Influence of isoproterenol on the norepinephrine stores in the rat heart.
    Dhalla NS; Balasubramanian V; Goldman J
    Can J Physiol Pharmacol; 1971 Apr; 49(4):302-11. PubMed ID: 5124930
    [No Abstract]   [Full Text] [Related]  

  • 27. Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants.
    Pettibone DJ; Totaro JA; Pflueger AB
    Eur J Pharmacol; 1984 Jul; 102(3-4):425-30. PubMed ID: 6489435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro effects on cardiac norepinephrine of angiotensin II and of two indirectly acting sympathomimetic amines (amphetamine and tyramine). A study of their combinations.
    Chevillard C; Alexandre JM
    Eur J Pharmacol; 1972 Aug; 19(2):223-30. PubMed ID: 4341975
    [No Abstract]   [Full Text] [Related]  

  • 29. 6-Chloro-2(1-piperazinyl) quinoxaline (CPQ): action on serotonin-induced behavioral responses and interactions with chloromethamphetamine and dimethyl-meta-tyramine.
    Lotti VJ; Clineschmidt BV; Haubrich D; Porter CC
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):103-15. PubMed ID: 153735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.
    Breese GR; Traylor TD
    J Pharmacol Exp Ther; 1970 Sep; 174(3):413-20. PubMed ID: 5456173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological effects of p-chloroamphetamine with respect to current amine hypotheses of affective disorders.
    Dewhurst WG; McKim HR
    Neuropsychobiology; 1980; 6(2):66-71. PubMed ID: 7354908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible relationship of the locus coeruleus--hippocampal noradrenergic neurons to depression and mode of action of antidepressant drugs.
    Kostowski W
    Pol J Pharmacol Pharm; 1985; 37(6):727-43. PubMed ID: 3008134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1971 May; 42(1):88-99. PubMed ID: 5580702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of desipramine on neuronal responses to tyramine and noradrenaline in the cerebral cortex [proceedings].
    Bevan P; Bradshaw CM; Pun RY; Slater NT; Szabadi E
    Br J Pharmacol; 1978 Mar; 62(3):402P-403P. PubMed ID: 638333
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain.
    Roffler-Tarlov S; Schildkraut JJ; Draskoczy PR
    Biochem Pharmacol; 1973 Nov; 22(22):2923-6. PubMed ID: 4148604
    [No Abstract]   [Full Text] [Related]  

  • 36. [Central action of beta-phenylethylamine derivatives. (7) Effects of intracerebral administration of tyramine on brain monoamine levels in mice].
    Sakurada S; Tadano T; Kisara K
    Nihon Yakurigaku Zasshi; 1976 May; 72(4):371-9. PubMed ID: 789195
    [No Abstract]   [Full Text] [Related]  

  • 37. Potentiation of the noradrenaline-releasing action of tyramine by monoamine oxidase inhibitors.
    Spano PF
    J Pharm Pharmacol; 1966 Aug; 18(8):548. PubMed ID: 4381864
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the responses of single cortical neurones to tyramine and noradrenaline: effects of desipramine.
    Bevan P; Bradshaw CM; Pun RY; Slater NT; Szabadi E
    Br J Pharmacol; 1978 Aug; 63(4):651-7. PubMed ID: 687876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study of the mechanism of action of the new antidepressant pyrazidol].
    MashkovskiÄ­ MD; Gorkin VZ; Andreeva NI; Verevkina IV; Siniukhin VN
    Farmakol Toksikol; 1975; 38(5):531-6. PubMed ID: 1183581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine.
    O'Donnell JM; Seiden LS
    J Pharmacol Exp Ther; 1984 Jun; 229(3):629-35. PubMed ID: 6427446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.